Search clinical trials for: Ergometrine Maleate

Total 912 results

Santen Pharmaceutical (Taiwan) Co., LTD

Completed

Preservative-free Fixed-dose Combination of Tafluprost 0.0015% / Timolol 0.5% in Patients With Open-angle Glaucoma or Ocular Hypertension: Clinical Effectiveness, Tolerability and Safety in a Real World Setting

Primary Open Angle Glaucoma | Ocular Surface Disease

Taiwan
Stanford University

Withdrawn

The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.

Ocular Hypertension | Glaucoma | Thyroid Eye Disease

United States
Cairo University

Not yet recruiting

Fractional Carbon Dioxide Laser: A Novel Therapeutic Option for Lichen Simplex Chronicus

Lichen Simplex Chronicus

Egypt
Cairo University

Not yet recruiting

Effect of Epigallocatechin-3-Gallate Solution as a Root Canal Irrigant on Post-Operative Pain Intensity and Bacterial Load Reduction in Necrotic Tooth

Necrotic Pulp
GlaxoSmithKline

Completed

Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034

Psoriasis

France
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Sunitinib in Treating Patients With Locally Advanced Bladder Cancer

Bladder Cancer

United States
US Oncology Research
Pfizer

Completed

Sunitinib Non Small Cell Lung Cancer Patients Over 70

Non Small Cell Lung Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Pfizer

Completed

Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment

Testicular Germ Cell Tumor | Ovarian Cancer | Teratoma | Extragonadal Germ Cell Tumor

United States
Pfizer

Completed

Safety And Efficacy Study Of Sunitinib Malate As First-Line Systemic Therapy In Chinese Patients With Metastatic Renal Cell Carcinoma (MRCC RCC)

Carcinoma, Renal Cell

China
Pfizer

Completed

Study In Patients With Kidney Cancer Treated With Sutent

Renal Cancer | Advanced or Metastatic Renal Cell Carcinoma

Slovakia
Juan P. Alderuccio, MD
ADC Therapeutics S.A.

Recruiting

Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma

Follicular Lymphoma

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Pfizer

Completed

Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Dana-Farber Cancer Institute

Completed

Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas

Sarcoma | Small Intestine Cancer | Ovarian Cancer | Endometrial Cancer | Desmoid Tumor | Adult Malignant Fibrous Histiocytoma of Bone

United States
vghtpe user

Terminated

A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population

Renal Cell Carcinoma

Taiwan
AEterna Zentaris

Completed

Perifosine + Sunitinib Malate for Patients With Advanced Cancers

Renal Cancer | GIST
Pfizer

Terminated

Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients

Metastatic Renal Cell Carcinoma

Philippines
Pfizer

Completed

Safety And Effectiveness Of Daily Dosing With 37.5 mg Sunitinib Malate In Patients With Advanced Kidney Cancer

Carcinoma, Renal Cell

Australia, Korea, Republic of, Brazil, Taiwan, Mexico, Argentina
Pfizer

Terminated

A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors

Carcinoma, Islet Cell | Carcinoma, Pancreas

United States, Canada, Belgium, Spain, Australia, Germany, Korea, Republic of, Taiwan, United Kingdom, France, Italy
Qlaris Bio, Inc.

Completed

A Study to Evaluate Safety and Tolerability of QLS-101 in NTG

Normal Tension Glaucoma (NTG)

United States
West China Hospital
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer

Breast Cancer | HER2 Positive | Combination Chemotherapy

China
Novartis Pharmaceuticals

Completed

Efficacy and Safety Study of QVA149 in COPD Patients

Chronic Obstructive Pulmonary Disease

United States
Novartis Pharmaceuticals

Completed

Lung Function and Patient Preference With QVA149 vs. Tiotropium in COPD Patients (FAVOR)

Chronic Obstructive Pulmonary Disease | COPD

Germany
Boryung Pharmaceutical Co., Ltd
The Catholic University of Korea

Completed

The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers

Peptic Ulcer

Korea, Republic of
Mariel Viviana Gómez
Maimonides University

Completed

Healing After Connective Tissue Graft Harvesting in the Palatal Area With and Without Suture

Wound Healing

Argentina
Bayer

Completed

US PROmyBETAapp2.0: A Study to Learn More About the Medication Usage and Patient Reported Outcomes Via the myBETAapp in Medical Care of Patients With Multiple Sclerosis Treated With BETASERON Using BETACONNECT Autoinjector

Multiple Sclerosis

United States
Graybug Vision

Completed

A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion

Diabetic Macular Edema | Retina Vein Occlusion

United States
M.D. Anderson Cancer Center
Pfizer

Terminated

Sunitinib Malate in Refractory Germ Cell Tumors

Genitourinary Disease

United States
Swiss Group for Clinical Cancer Research

Completed

Sunitinib in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Liver Cancer

Switzerland
Rambam Health Care Campus

Unknown

Solifenacin Succinate Versus Fesoterodine A Comparison Trial for Urgency Symptoms

Urinary Bladder, Overactive

Israel
M.D. Anderson Cancer Center
Pfizer

Completed

Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer

Kidney Cancer | Renal Cell Cancer

United States
California Pacific Medical Center Research Institute
Pfizer; University of California, San Francisco

Completed

Clinical Trial of Sutent to Treat Metastatic Melanoma

Metastatic Melanoma

United States
Australasian Sarcoma Study Group
Pfizer; Peter MacCallum Cancer Centre, Australia

Unknown

Sunitinib and Radiation in Patients With Resectable Soft-tissue Sarcoma (SUNXRT)

Soft Tissue Sarcoma

Australia
Institut Curie

Completed

Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell Cancer

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter

France
Pfizer

Completed

Special Investigation For Renal Cell Carcinoma (RCC) Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan)

Carcinoma, Renal Cell
US Oncology Research
Pfizer

Completed

Phase II Sunitinib Prog Met AIPC

Metastatic Prostate Cancer

United States
Pfizer

Completed

A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer (S-TRAC)

Kidney Neoplasms

United States, Spain, United Kingdom, France, Ireland, Sweden, Taiwan, Germany, Czechia, Korea, Republic of, Malaysia, Israel, Slovakia, China, Poland, Denmark, Switzerland, Italy, Australia, Colombia, Greece, Mexico
Pfizer

Completed

Safety And Efficacy Study Of Sunitinib Malate In Chinese Patients With Imatinib Resistant Or Intolerant Malignant Gastrointestinal Stromal Tumor (GIST)

Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors

China
Duke University
Pfizer

Completed

Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to Prostatectomy

Prostate Cancer | Prostatectomy

United States
Pfizer

Completed

A Phase I/II Study of Sunitinib Malate (SU011248) In Patients With Gastrointestinal Stromal Tumor (GIST)

Gastrointestinal Stromal Tumors

Japan
Eisai Inc.

Terminated

A Phase 3, Multicenter, Randomized, Double-blind,Active-controlled, Parallel-group Trial With an Open-labelExtension Phase to Evaluate the Efficacy and Safety of OralE5501 Versus Eltrombopag, in Adults With Chronic ImmuneThrombocytopenia (Idiopathic Thrombocytopenic Purpura)

Idiopathic Thrombocytopenic Purpura

United States
Medicure

Completed

MEND-CABG (MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery)

Myocardial Ischemia | Reperfusion Injury | Coronary Artery Bypass Graft Surgery | Myocardial Revascularization

Canada, United States
University of Colorado, Denver

Recruiting

Prochlorperazine Maleate Versus Placebo for the Prophylaxis of Acute Mountain Sickness

Acute Mountain Sickness

United States
Wills Eye
Optovue

Completed

Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study

Primary Open-angle Glaucoma | Normal Tension Glaucoma | Glaucoma; Drugs

United States
Aerie Pharmaceuticals

Completed

Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-angle Glaucoma

United States
Pharmaceutical Research Network

Completed

Lumigan Versus Cosopt

Open-Angle Glaucoma

United States
Lo.Li.Pharma s.r.l

Completed

Effect of Natural Compounds on the Severity of HPV-induced Cervical Lesions

Papilloma | Cervix Lesion

Italy
Bayer

Completed

Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon (BETAPREDICT)

Multiple Sclerosis

Germany
Purdue University
National Institutes of Health (NIH)

Terminated

Salivary Interactions With Chemosensations

Diet, Food Choice, Taste

United States
Pfizer

Completed

Special Investigation For Gist Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan).

Gastrointestinal Stromal Tumors
Rutgers, The State University of New Jersey
National Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey

Terminated

Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer

Kidney Cancer

United States

Search clinical trials for: Ergometrine Maleate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations